Oklo Inc. Class A common stock (OKLO)

Oklo is poised to become one of nuclear energy's biggest winners.

The microreactor maker plans to deploy new reactors at a "world record" speed.

The nuclear start-up's stock is down about 77% from its 52-week high. Its operating record went the other direction.

Nuclear is booming, and the smartest money may be flowing to the companies already selling the power, equipment, and fuel.

GE Vernova is quietly building embedded value with its long-term SMR investments.

Stocks eye a third winning week as strong earnings from SoundHound, Albemarle and CAVA offset mixed results, with MarketBeat analysts covering NVIDIA, Lockheed Martin, GE Vernova and more.

Oklo's next-gen nuclear technology could deliver massive long-term returns, but investors should know a few things before diving into the stock.

Oklo had a disastrous market debut. Investors who held on to their shares, however, have had the last laugh.

Both energy stocks are attracting significant attention, but one is clearly the better buy.

SpaceX is the largest space company, while Oklo is an early-stage energy company.

As AI fuels demand for power, these companies are well-positioned to meet the moment.

A nuclear energy company made a big breakthrough. Will it lead to bigger profits for these nuclear energy ETFs?

The sale sounds like a lot, but the CEO still has skin in the game with nearly 472,000 shares owned directly.

There's one thing you must know before you buy Oklo stock.

Oklo posted its first revenue in Q2, with isotope, fuel, and small modular reactor businesses set to ramp through 2028, while a $3 billion cash position eases dilution concerns.

It's a bit of a speculative investment right now, but there are encouraging signs.

Oklo just reported its first-ever quarterly revenue.

Uranium Energy and Oklo stand to benefit from powerful tailwinds behind the nuclear energy industry, but only one stock stands out as a better play right now.

Oklo Inc. (NYSE:OKLO) reported Q2 revenue of $1.21 million, beating estimates. 2026 cash flow expected at $120-150 million, shares down 7.7%.

Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project

What does $12 billion of market value buy when combined sales run about $12 million?

Nuclear energy will be a multi-trillion-dollar opportunity.

Groves facility reaches first criticality in under 11 months.

Oklo achieved a crucial milestone.